36th Annual Meeting and Exposition
of the Controlled Release Society
July 18-22, 2009
Bella Center
Copenhagen, Denmark
Bioactive Materials Program Highlights
Biomaterials for Medicines
Nicola Tirelli, University of Manchester, U.K.
Blood Brain Barrier
Joerg Kreuter, University of Frankfurt, Germany, Nanoparticles as a Tool for Overcoming the Blood Brain Barrier
Characterization Techniques-New Approaches
Mike Reading, University of East Anglia, U.K., New Thermal and Photothermal Techniques for Pharmaceutical Materials Characterization Gene Therapy
Chun Wang, University of Minnesota, U.S.A., Engineering Polymers for DNA Vaccine Delivery
Imaging Technologies for Diagnostics and Treatment
Zheng-Rong Lu, University of Utah, U.S.A., Contrast Enhanced MRI in Drug Development
Inhaled Medicines
Thomas Kissel, Philipps University, Germany, Nano-Carriers for Pulmonary Drug and Gene Delivery
Tamara Minko, Rutgers University, U.S.A., Inhalatory Co-delivery of Anticancer Drugs and Antisense Oligonculeotides/siRNA for Lung Cancer Treatment
Inorganic Nanoparticles
Giovanni Baldi, Colorobbia, Italy, Nano Theranostic: Magnetic Nanoparticles for Cancer Diagnosis and Therapy
Leading Edge Device Technologies
Orest Lastow, AstraZeneca, Sweden, How Should the Next Generation Inhalation Device Address the Patient Needs of the Future?
Robert Levy, Children’s Hospital of Philadelphia, U.S.A., Gene Delivery Stents: Strategies for Variable Dosing and Sustained Transgene Expression
Liposomes and Micelles
Vladimir Torchilin, Northeastern University, U.S.A., Liposomes and Polymeric Micelles as Pharmaceutical Carriers: New Horizons
Membrane Transporters–Crossing Biological Barriers
Mark Gumbleton, Cardiff University, U.K.
Nanomedicines
Hamid Ghandehari, University of Utah, U.S.A., Nanoconstructs for Controlled Delivery: Towards a Higher Degree of Definition
Nanotechnology and Animal Models: Improving Health Outcomes – an Animal Health/Veterinary and Bioactive Materials Joint Session
Patrick Couvreur, University of Paris-XI, France, Squalenoylation: A Platform for the Discovery of New Anticancer and Antiviral Nanomedicines
Jean-Christophe Leroux, University of Zurich, Switzerland, Evaluation of Gliadin/Polymer Nanocomplexes in a Mouse Model of Gluten Sensitivity
Nasal Drug Delivery
Erik Bjork, University of Uppsala, Sweden
New Candidates for Polymer Therapeutics
Paolo Ferruti, University of Milan, Italy
Etienne Schacht, University of Ghent, Belgium
New Materials for Nanotechnology
Dennis Discher, University of Pennsylvania, U.S.A.
Oral Controlled Release Technologies
Paolo Colombo, University of Parma, Italy, Drug Delivery Modules and Assemblage Technology for Combined Product Development
Abraham Rubinstein, Hebrew University of Jerusalem, Israel, Targeting GI Mucosal Diseases via the Oral Route: Design Strategies
Oral Delivery-Improving Absorption
Paul Dickinson, AstraZeneca, U.K., AstraZeneca, U.K.
Ijeoma Uchegbu, University of London, U.K., Shuttling Drug Molecules Across the Gut Ephithelium: From the Molecule to the Medicine
PEG-Based Systems: Modulating Pharmacokinetics with Polymers
Paolo Caliceti, University of Padova, Italy, PEGnology: State of the Art and Perspectives
Peptide and Protein Medicines
Simon Richardson, University of Greenwich, U.K., Copying Nature in Order to Safely Deliver Macromolecules to the Cytosol: The Use of Polymers and Recombinant Proteins
siRNA Therapy
David Rozema, Mirus Bio Corporation/University of Wisconsin, U.S.A., Dynamic PolyConjugates: A Rationally Designed, Modular Platform for Systemic siRNA Delivery
Stents
Clive Roberts, University of Nottingham, U.K.
Tissue Engineering
Ann-Christine Albertsson, University of Sweden, Sweden, Towards an Ideal Polymer Scaffold for Bone Tissue Engineering
Transdermal
Diane Burgess, University of Connecticut, U.S.A., Nanotechnology Approaches in Transdermal Drug Delivery
Tumor Targeting
Kazunori Kataoka, University of Tokyo, Japan, Smart Supramolecular Nanodevices for Tumor Targeting
Vaccines
David Putnam, Cornell University, U.S.A., Delivery of Foreign Antigens by Engineered Outer Membrane Vesicle Vaccines
All speakers, topics, and titles are subject to change.
|